New York, US – July 19, 2019 Recently, Creative Biolabs has introduced a well defined gene sequence into the specific cells aiming at inducing protein secretory substance with putative therapeutic function, which benefits from the suite of services covering development of gene delivery systems like adenovirus vector and design of therapeutic strategies that contain oncolytic virus development, antisense oligonucleotide, RNAi, microRNA and, suicide gene therapy service.
Delivery systems – viral vector development at Creative Biolabs
Several gene therapy GMP certified platforms are served to improve the design and construction of viral vectors, including lentiviral vector, adenovirus vector, herpes simplex virus vector, adeno-associated virus vector and so forth, which meet diversified needs of clients throughout the world. Aiming at helping customers to choose the most suitable vector for transferring exact number of the foreign genes to target cells and hence to induce expression without cytotoxicity, years of time and energy has been spent by the scientists from Creative Biolabs, and the achievements will definitely push customers’ projects forward by a large margin on a broad scale of the medical area.
Viruses development services at Creative Biolabs
Oncolytic virus (OV) development emerges as time requires when the gene therapy treatment is receiving ascending popularity in the medical area. Creative Biolabs’ OV products through the propagation of the virus, cytotoxic proteins expression and cell lysis can infect cancer cells and induce cell death with outstanding performance. A series of original viruses are designed and utilized for GT solutions, which include vaccinia virus, adenovirus virus, herpes simplex virus type I/II, reovirus, Newcastle disease virus, and vesicular stomatitis virus.
Antisense oligonucleotides (ASOs) for binding the target RNA are modulated, which have promising potential to facilitate antisense oligonucleotides therapeutics targeting at human diseases like cancer.
The RNA interference (RNAi) developing services operate in accordance with sequence design, design of chemical substance, the innate immune recognition and delivery, which have broadly applicable facets and serve as a strong tool to analyze gene. The special siRNA (small interfering RNA) and shRNA (short hairpin RNA) products are adopted specifically for target validation and hence enhance therapeutic benefit accordingly.
Downregulating the microRNA (miRNA)-caused gene stands as another feature service of Creative Biolabs that utilizes methods like translational repression and mRNA degradation to satisfy clients’ multiple requirements and standards.
The two suicide GT strategies (cytosine deaminase/5-fluorocytosine and the herpes simplex virus/ganciclovir) combined with the outstanding delivery systems can successfully deliver the suicide genes that are applicable to cancers like colon cancer, head and neck, bladder cancer, etc.
Working in the area of Gene Therapy for more than a decade, accumulated experience and proficient methods of Creative Biolabs continuously attract global clients in the relevant area. With the aim of improving the precise medicine in an efficient way, the one-stop-service mode makes up the vacancy and improves the standards of the whole industry. For the projects regarding GT, it’s never too late to contact Creative Biolabs for improvement at https://www.creative-biolabs.com/gene-therapy/.
About Creative Biolabs:
With years of experience in providing one-stop pre-clinical development services, Creative Biolabs has built a team of experts with solid knowledge regarding gene therapy who are fully competent in assisting global clients. Services include but are unlimited to delivery vehicle development, potency tests, safety and toxicology analysis, solutions of specific gene therapy development for diseases, etc.
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States